Cobimetinib

Chemical formula: C₂₁H₂₁F₃IN₃O₂  Molecular mass: 531.318 g/mol  PubChem compound: 16222096

Therapeutic indications

Cobimetinib is indicated for:

Metastatic melanoma with a BRAF V600 mutation

Population group: only adults (18 years old or older)

Cobimetinib is indicated for use in combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.